Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-15 01:04 |
FORM F-3-mendment No. 1-TO PROSPECTUS Dated April 14, 2023
|
English | 36.0 KB | ||
| 2023-04-15 01:04 |
Amendment No. 1 to Form F-2 TO PROSPECTUS Dated April 14, 2023
|
English | 325.7 KB | ||
| 2023-04-15 01:04 |
Amendment No. 1 to Form F-2 TO PROSPECTUS Dated April 14, 2023
|
English | 36.0 KB | ||
| 2023-03-31 01:04 |
FORM F-3-REGISTRATION STATEMENT
|
English | 480.5 KB | ||
| 2023-03-31 01:04 |
FORM F-3-REGISTRATION STATEMENT
|
English | 35.9 KB | ||
| 2023-03-15 13:59 |
קומפיוג'ן מציגה מחקר חדש שמאפשר זיהוי מדויק של PVRIG בכנס של האגודה האמריקנית ל…
|
English | 109.6 KB | ||
| 2023-03-15 13:59 |
קומפיוג'ן מציגה מחקר חדש שמאפשר זיהוי מדויק של PVRIG בכנס של האגודה האמריקנית ל…
|
English | 36.1 KB | ||
| 2023-03-11 01:25 |
Silicon Valley Bank was closed by the California Department of Financial Protec…
|
English | 61.8 KB | ||
| 2023-03-11 01:25 |
Silicon Valley Bank was closed by the California Department of Financial Protec…
|
English | 35.9 KB | ||
| 2023-03-08 14:59 |
Participate in a Fireside Chat at the Oppenheimer 33rd Annual Healthcare Confer…
|
English | 82.8 KB | ||
| 2023-03-08 14:59 |
Participate in a Fireside Chat at the Oppenheimer 33rd Annual Healthcare Confer…
|
English | 36.0 KB | ||
| 2023-03-06 14:59 |
Compugen Doses First Patient in Triple Combination COM701,COM902 and Pembrolizu…
|
English | 106.9 KB | ||
| 2023-03-06 14:59 |
Compugen Doses First Patient in Triple Combination COM701,COM902 and Pembrolizu…
|
English | 36.1 KB | ||
| 2023-02-28 14:59 |
FORM 20-F For the fiscal year ended December 31, 2022
|
English | 1.0 MB | ||
| 2023-02-28 14:59 |
FORM 20-F For the fiscal year ended December 31, 2022
|
English | 36.1 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
